Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 57.25
+0.75 (1.33%)
At close: Nov 5, 2025
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 6.48 billion as of November 6, 2025. Its market cap has increased by 114.99% in one year.
Market Cap
6.48B
Enterprise Value
5.47B
Revenue
352.91M
Ranking
n/a
PE Ratio
155.40
Stock Price
57.25
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 6.48B, a decrease of -37.89%. That is a compound annual growth rate of -13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 6.52B | 57.08% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 411.17B |
| WuXi AppTec | 277.01B |
| Shenzhen Mindray Bio-Medical Electronics | 250.34B |
| Sichuan Biokin Pharmaceutical | 149.46B |
| Shanghai United Imaging Healthcare | 112.34B |
| Aier Eye Hospital Group | 111.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.88B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |